Effects of a short-term fasting mimicking diet on quality of life and tolerance to chemotherapy in patients with cancer
OwnerAndreas Michalseninventor
Life of this patent
Estimating the term…
Abstract
An anti-cancer agent for use in a method for the treatment of cancer, in particular gynecological cancer, in a patient, wherein the method comprises subjecting said patient to a plurality of therapy cycles, in particular chemotherapy cycles, with the anti-cancer agent, which can be a chemotherapeutic agent, and subjecting said patient to a fasting mimicking diet (FMD) for a period of 30-42 hours before each therapy cycle and 18-30 hours after each therapy cycle.
Claims26
1-44. (canceled)
A method of increasing the Quality-Of-Life (QOL) and reducing the fatigue of a human patient with cancer being subjected to therapy cycles with an anti-cancer agent, which method comprises subjecting said patient to a plurality of therapy cycles with said anti-cancer agent and subjecting said patient to a fasting mimicking diet (FMD) for a period of 30-42 hours before each therapy cycle and 18-30 hours after each therapy cycle.
An improved method of treating a human patient with cancer, comprising a step of subjecting said patient to a plurality of therapy cycles with an anti-cancer agent, the improvement consisting in subjecting said patient to a fasting mimicking diet (FMD) for a period of 30-42 hours before each therapy cycle and 18-30 hours after each therapy cycle, thus obtaining an increase of the patient's Quality-Of-Life (QOL) and a fatigue reduction.
Dependencies are inferred from the claim text.